Certified by Founder Lodge
BioLoomics, Inc.
United States - Boulder, CO
START UP
1 Disclosed Funding Rounds $8,700,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
BioLoomics is a preclinical stage biotechnology company leveraging directed evolution of antibodies in human cells to create target degrading antibodies. Our proprietary tech combines single-
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 20 ,2023 | Seed | $8,700,000 |
Horizons Ventures
Innovation Endeavors
TECHU
Boom Capital
BoxOne Ventures
Enveda Biosciences
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Distru | $6,000,000 | (Nov 21, 2024)
Qminder | $3,164,550 | (Nov 21, 2024)
CellPoint Digital | $30,000,000 | (Nov 21, 2024)
Flywl | $7,000,000 | (Nov 21, 2024)
juna.ai | $7,500,000 | (Nov 21, 2024)
